Tiziana Life Sciences Ltd (TLSA)
NASDAQ: TLSA · Real-Time Price · USD
1.180
-0.180 (-13.24%)
Jun 3, 2026, 4:00 PM EDT - Market closed
Tiziana Life Sciences Market Cap
Tiziana Life Sciences has a market cap or net worth of $152.58 million as of June 4, 2026. Its market cap has increased by 0.66% in one year.
Market Cap
152.58M
Enterprise Value
149.03M
1-Year Change
0.66%
Ranking
Category
Stock Price
$1.18
Market Cap Chart
Since October 21, 2021, Tiziana Life Sciences's market cap has increased from $145.96M to $152.58M, an increase of 4.54%. That is a compound annual growth rate of 0.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 175.86M | -0.67% |
| Dec 31, 2025 | 177.05M | 133.12% |
| Dec 31, 2024 | 75.95M | 34.82% |
| Dec 29, 2023 | 56.33M | -7.14% |
| Dec 30, 2022 | 60.66M | -35.06% |
| Dec 31, 2021 | 93.41M | -36.00% |
| Oct 21, 2021 | 145.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Equillium | 192.21M |
| Turn Therapeutics | 191.24M |
| Milestone Pharmaceuticals | 187.75M |
| Korro Bio | 186.63M |
| Acumen Pharmaceuticals | 183.46M |
| Precision BioSciences | 183.20M |
| MediWound | 178.13M |
| NRx Pharmaceuticals | 173.38M |